Behrens M Kathleen
- SEC CIK
- 0001211701
No open-market purchases or sales filed in the past year.
Current role at each company
- SRPT Sarepta Therapeutics, Inc.Directoras of Jun 5, 2026
- IGMS IGM Biosciences, Inc.Directoras of Aug 14, 2025
- MDXG Mimedx Group, Inc.Directoras of Jun 23, 2025
Open-market trades in the past year
Open-market purchases (P) and sales (S) filed in the last 365 days, not counting derivative securities or duplicate filings. Values leave out price outliers.
- Bought
- –
- 0 filings
- Sold
- –
- 0 filings
- Net
- –
- Bought minus sold
- Companies
- 0
- With open-market trades
Trades
Every Form 4 that lists Behrens M Kathleen as a reporting owner, including filings made jointly with others, grouped by company. Each row adds up one type of transaction in one filing. Only open-market purchases (P) and sales (S) are shown by default.
IGMS IGM Biosciences, Inc.
Director3 trades
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Jun 28, 2023 (view filing) | Jun 26 | 2 days | Behrens M KathleenDirector | PPurchase | +112.5K | $8.00 | +$900.0K | +51.6%330.7K after | |
| Nov 10, 2022 (view filing) | Nov 8 | 2 days | Behrens M KathleenDirector | PPurchase | +60.0K | $17.14 | +$1.03M | +37.9%218.2K after | |
| Apr 4, 2022 (view filing) | Apr 1 | 3 days | Behrens M KathleenDirector | PPurchase | +60.9K | $23.00 | +$1.40M | New position29.8K after | 3 lots |